Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : T.ITE: iTech Capital (TSE) -- Ignore unavailable to you. Want to Upgrade?

To: mappingworld who wrote (3459)	12/28/1999 9:51:00 PM
From: teevee	Read Replies (1) \| Respond to of 5053

Olga, Thanks. I have been very busy reading all the b2b URL's you have been kind enough to provide. In particular, I found this one to be very helpful(an "eye opener" would be more accurate), especially all the graphs and tables it contained: netmarketmakers.com The market for the Horizonlive.com's product in the B2B arena is HUGE....I have no doubt that JDX will be participating in further funding in this company as it did with Medsite.....I also interpreted who they have strategic alliances with on the technical and delivery side of their product as an endorsement by leaders in the field. One comment I found interesting is that there is a backlog of about 83 IPO's....it will be interesting to see if Medsite's IPO gets done fairly early in 2000(in the first quarter). I would interpret that as an indication of Medsite's relative potential and importance. Also, the US prices for B2B startups and incubators are well above the current share price of JDX. Nice job on the new "B2B in Canada" thread you started. I wouldn't be surprised if all the Jordex discussion migrated over there. Although the "B2B in Canada" thread is new, the influx of new and knowledgeable posters was immediate. Also, it should be very helpful in introducing Jordex to American B2B investors. regards, teevee